Insider profile
Biotech ApS WG Insider Trading
This page tracks every SEC Form 4 filing since April 2023 by Biotech ApS WG: 9 transactions in total, including 8 open-market purchases and 0 sales. Each record is parsed directly from the original filing, with amendments reconciled so a corrected filing never double-counts.
- Role
- Director
- CIK
- 0001753193
- Companies traded
- 1
- Total filings
- 9
- First filing
- 2023-05-15
- Last filing
- 2025-09-16
Files as WG Biotech ApS · SEC EDGAR ↗
Activity summary
The most recent open-market decision, on December 11, 2023, was 2 purchases totaling 109,318 shares ($765K).
Three year balance
Buy and sell value by quarter, Q2 23 to Q3 25. Biotech ApS WG has been a net buyer across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.8M.
Insider insight
Biotech ApS WG trades most actively in YMAB, accounting for 8 of the 9 filings on record. The largest single open-market purchase on record is $981K in YMAB, filed May 2023.
Track record
Most active in
Transaction History
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
Showing 5 of 9 transactions. The most significant are picked first.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 11, 2023 | Biotech ApS WG | YMAB | Purchase | 102,863 | $7.01 | $721K |
| Nov 29, 2023 | Biotech ApS WG | YMAB | Purchase | 51,837 | $5.97 | $309K |
| Nov 28, 2023 | Biotech ApS WG | YMAB | Purchase | 30,671 | $5.81 | $178K |
| Nov 27, 2023 | Biotech ApS WG | YMAB | Purchase | 62,516 | $5.49 | $343K |
| May 15, 2023 | Biotech ApS WG | YMAB | Purchase | 101,740 | $9.65 | $981K |
4 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/insiders/0001753193/transactions" \
-H "X-Api-Key: $KEY"Companies traded
By number of filings.
Filing cadence
Filings per quarter, this window.
Busiest: Q4 23 (7 filings)
Quietest: Q3 23 (0 filings)
Reading an insider's Form 4 history
Corporate insiders (directors, officers, and holders of more than 10% of a company's stock) must report their trades to the SEC on Form 4 within two business days. Looking at one insider's filings over time shows whether they tend to buy on the open market (a discretionary use of their own money, generally the strongest signal), sell, or simply receive and exercise equity awards as compensation.
The track record above measures how this insider's past open-market purchases performed in the months after each filing. Trades made under a pre-scheduled Rule 10b5-1 plan are flagged because they carry no timing signal. To pull any insider's full history programmatically, see the insider trading API or our guide to reading Form 4 filings.